HPS Pharmacies wish to advise that Pharmaco Australia is experiencing a supply interruption for Zyprexa® IM as follows:
Olanzapine 10mg
ARTG 76867
This supply interruption is expected to be resolved by the end of July 2025.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. This product is registered in the USA and all labelling is in English.
Please note that S19A products may have a longer lead time as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pharmaco on 1800 201 564or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates